These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17786785)
1. Nasopharyngeal cancer of childhood and adolescence: a single institution experience. Venkitaraman R; Ramanan SG; Sagar TG Pediatr Hematol Oncol; 2007; 24(7):493-502. PubMed ID: 17786785 [TBL] [Abstract][Full Text] [Related]
2. Results of combined modality treatment for nasopharyngeal cancer. Venkitaraman R; Ramanan SG; Vasanthan A; Sagar TG J Cancer Res Ther; 2009; 5(2):102-6. PubMed ID: 19542665 [TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741 [TBL] [Abstract][Full Text] [Related]
4. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. Chan AT; Leung SF; Ngan RK; Teo PM; Lau WH; Kwan WH; Hui EP; Yiu HY; Yeo W; Cheung FY; Yu KH; Chiu KW; Chan DT; Mok TS; Yau S; Yuen KT; Mo FK; Lai MM; Ma BB; Kam MK; Leung TW; Johnson PJ; Choi PH; Zee BC J Natl Cancer Inst; 2005 Apr; 97(7):536-9. PubMed ID: 15812080 [TBL] [Abstract][Full Text] [Related]
5. Treatment outcome of locally advanced nasopharyngeal cancer with concurrent chemoradiotherapy. Yarney J; Vanderpuye V; Kitcher ED West Afr J Med; 2008 Apr; 27(2):65-8. PubMed ID: 19025016 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence]. Cao KJ; Li Y; Xie GF; Hong MH Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):134-7. PubMed ID: 16750020 [TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma. Lee CC; Chu ST; Chou P Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399 [TBL] [Abstract][Full Text] [Related]
9. A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: the Kinki University experience. Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Koike R; Okubo M; Nishikawa T; Tachibana I; Tamura M; Okumura M Jpn J Clin Oncol; 2010 Feb; 40(2):130-8. PubMed ID: 19841102 [TBL] [Abstract][Full Text] [Related]
10. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma. Lee CC; Chu ST; Chou P; Lee CC; Chen LF Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377 [TBL] [Abstract][Full Text] [Related]
11. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Tham IW; Hee SW; Yeo RM; Salleh PB; Lee J; Tan TW; Fong KW; Chua ET; Wee JT Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1481-6. PubMed ID: 19386431 [TBL] [Abstract][Full Text] [Related]
12. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356 [TBL] [Abstract][Full Text] [Related]
13. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study. Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164 [TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. Kang SY; Oh YT; Han JH; Choi JH; Lim HY; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Chun M; Kim CH; Joo HJ Neoplasma; 2006; 53(5):450-6. PubMed ID: 17013542 [TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population. Airoldi M; Gabriele AM; Garzaro M; Raimondo L; Condello C; Beatrice F; Pecorari G; Giordano C Radiother Oncol; 2009 Jul; 92(1):105-10. PubMed ID: 19264368 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712 [TBL] [Abstract][Full Text] [Related]
17. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma. Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742 [TBL] [Abstract][Full Text] [Related]
18. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296 [TBL] [Abstract][Full Text] [Related]